Previous studies have detected IDO expression in tumor cells, blood vessels, stromal cells of NSCLC patients, as well as in dendritic cells (DCs) in the tumor environment and tumor-related lymph nodes in patients with LC (33). This evidence concerns the gene IDO1 and neoplasm.